Predictors of difficulty when discontinuing postmenopausal hormone therapy

Author： Grady D. Ettinger B. Tosteson A.N.A. Pressman A. Macer J.L.

Publisher： Elsevier

ISSN： 0029-7844

Source： Obstetrics and Gynecology, Vol.102, Iss.6, 2003-12, pp. : 1233-1239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Predictors of intentions to use hormone replacement therapy in clinical postmenopausal women

By Simpson E. E. A.

Climacteric, Vol. 15, Iss. 2, 2012-04 ,pp. : 173-180

Informa Healthcare

Access to resources Recommend Favorite

WEIGHING THE CONS AND PROS: WOMEN'S REASONS FOR DISCONTINUING HORMONE REPLACEMENT THERAPY

By McClennan Reece Susan

Health Care For Women International, Vol. 23, Iss. 1, 2002-01 ,pp. : 19-32

Routledge Ltd

Access to resources Recommend Favorite

Postmenopausal hormone therapy and lung cancer

By Pines A.

Climacteric, Vol. 14, Iss. 2, 2011-04 ,pp. : 212-214

Informa Healthcare

Access to resources Recommend Favorite

Postmenopausal hormone therapy and the risk of venous thromboembolism

By Rachon D. Teede H.

Climacteric, Vol. 11, Iss. 4, 2008-01 ,pp. : 273-279

Informa Healthcare

Access to resources Recommend Favorite

Health risks after cessation of postmenopausal hormone therapy

By Pines Amos Sturdee David Birkhauser Martin

Climacteric, Vol. 11, Iss. 3, 2008-01 ,pp. : 179-180

Informa Healthcare

Access to resources Recommend Favorite